HOME >> BIOLOGY >> NEWS
New hope for Chagas disease treatment

Chagas disease, which is transmitted to humans by a blood-sucking insect known as an Assassin bug, is the most devastating parasitic infection in Central and South America and Mexico. The protozoan parasite that causes the disease, Trypanosoma cruzi, infects 16 to 18 million people, causing severe chronic illness and tens of thousands of deaths per year.

Until now, there has been no effective treatment for the long-term, chronic form of Chagas disease, which kills up to one-third of those infected, usually by heart failure. However, two Howard Hughes Medical Institute (HHMI) international research scholars have now found that in mice, a compound called TAK-187 is significantly more effective than the current standard of care the drug benznidazole in preventing T. cruzi-induced cardiac damage. Julio Urbina from theVenezuelan Institute for Scientific Research and Miguel Angel Basombro from the National University of Salta and colleagues report their findings in the April issue of the journal Antimicrobial Agents and Chemotherapy.

Benznidazole, a drug used to treat acute, recent Chagas infections, often has toxic side effects and does not work once the disease has entered its chronic phase. As an alternative, Urbina, Basombro, and colleagues tested TAK-187, a compound that prevents T.cruzi from producing a member of the steroid family called ergosterol, which is essential to the parasite's life cycle. The compound is currently in development as a systemic antifungal agent, but the results of the current study suggest that drugs of this type, which inhibit ergosterol synthesis, could be a "superior alternative to currently available therapy in the management of chronic Chagas disease," Urbina and Basombro write in their report.

The scientists infected a group of mice with T.cruzi, then treated those mice with either TAK-187, benznidazole, or nothing at all. While both drugs completely eliminated T.cruzi from the blood of infected animal
'"/>

Contact: Jennifer Donovan
donovanj@hhmi.org
240-401-5783
Howard Hughes Medical Institute
31-Mar-2005


Page: 1 2 3

Related biology news :

1. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics
2. Loyola prof. aids in discovery of first case of insect transmission of Chagas parasite in Louisiana
3. Researchers at UGA provide first look at protein expression in Chagas disease-causing parasites
4. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
5. Antioxidant overload may underlie a heritable human disease
6. Female gender provides an advantage in renal diseases
7. The female advantage in kidney disease does not extend to diabetic women
8. Link between sunspots, rain helps predict disease in east Africa
9. Cornell scientists link E. coli bacteria to Crohns disease
10. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
11. Link identified between Alzheimers disease and glaucoma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 04, 2018 , ... Urological Associates ... a UroLift® Center of Excellence. The designation recognizes that Dr. Choi has achieved ... a commitment to exemplary care for men suffering from symptoms associated with Benign ...
(Date:11/29/2018)... ... November 29, 2018 , ... Tosoh ... the intention of acquiring full ownership. The transaction was approved by the Board ... November 14, 2018. “We are extremely pleased to team up with Tosoh Bioscience ...
(Date:11/27/2018)... N.J. and CARLSBAD, Calif. (PRWEB) , ... November ... ... John Wiley & Sons. The companies have worked together to integrate the ... TAs and students. The combined offering will be available beginning January of ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... N.H. and PHILADELPHIA (PRWEB) , ... November 08, ... ... 25-year-old control system integrator of custom industrial automation and IT solutions with 140 ... be exhibiting at Automation Fair®, taking place at the Pennsylvania Convention Center on ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial ... trial data collection and management. TrialKit ™, an eClinical platform, has incorporated ... can quickly and easily sign in to the app via facial recognition or ...
(Date:11/5/2018)... NEW YORK (PRWEB) , ... November 05, 2018 ... ... test, is launching live educational support for healthcare professionals through its website, ... support will offer a live chat and video option via the website in ...
(Date:11/3/2018)... N.C. (PRWEB) , ... November 01, 2018 , ... Triangle ... by Inc. Magazine as one of the fastest-growing private companies in the United States, ... Inc. 5000 list ranks private companies based on percentage revenue growth over the previous ...
Breaking Biology Technology:
Cached News: